OrthoPediatrics Corp. (NASDAQ:KIDS) Short Interest Update

OrthoPediatrics Corp. (NASDAQ:KIDS) was the recipient of a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 1,100,000 shares, a drop of 5.2% from the May 15th total of 1,160,000 shares. Currently, 6.8% of the shares of the stock are sold short. Based on an average trading volume of 151,700 shares, the days-to-cover ratio is presently 7.3 days.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on KIDS shares. Needham & Company LLC lifted their target price on shares of OrthoPediatrics from $37.00 to $42.00 and gave the stock a “buy” rating in a research note on Tuesday, May 7th. JMP Securities reissued a “market outperform” rating and set a $50.00 price target on shares of OrthoPediatrics in a research report on Tuesday, May 7th. Finally, Truist Financial boosted their price target on shares of OrthoPediatrics from $35.00 to $38.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th.

Institutional Trading of OrthoPediatrics

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Blue Trust Inc. increased its stake in OrthoPediatrics by 1.5% during the fourth quarter. Blue Trust Inc. now owns 28,670 shares of the company’s stock worth $917,000 after purchasing an additional 421 shares during the period. Charles Schwab Investment Management Inc. grew its position in shares of OrthoPediatrics by 0.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 121,731 shares of the company’s stock worth $3,895,000 after buying an additional 549 shares in the last quarter. Swiss National Bank grew its position in shares of OrthoPediatrics by 2.4% during the third quarter. Swiss National Bank now owns 38,500 shares of the company’s stock worth $1,232,000 after buying an additional 900 shares in the last quarter. CWM LLC grew its position in shares of OrthoPediatrics by 16,283.3% during the fourth quarter. CWM LLC now owns 983 shares of the company’s stock worth $32,000 after buying an additional 977 shares in the last quarter. Finally, EntryPoint Capital LLC grew its position in shares of OrthoPediatrics by 56.9% during the first quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock worth $81,000 after buying an additional 1,009 shares in the last quarter. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

OrthoPediatrics Trading Up 0.4 %

Shares of KIDS stock opened at $29.42 on Tuesday. OrthoPediatrics has a twelve month low of $23.10 and a twelve month high of $46.58. The company’s 50-day moving average price is $31.39 and its 200-day moving average price is $29.80. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.45 and a quick ratio of 1.99.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings results on Monday, May 6th. The company reported ($0.30) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.42) by $0.12. The company had revenue of $44.69 million for the quarter, compared to analyst estimates of $41.63 million. OrthoPediatrics had a negative net margin of 13.58% and a negative return on equity of 5.12%. As a group, equities analysts expect that OrthoPediatrics will post -1.2 earnings per share for the current year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.